文献速递核素与放射性配体治疗肿瘤 PET/CT放射性药物与辐射防护

放射性诊疗一体化实施:挑战、障碍与IAEA可持续可及策略

Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access.
PubMed 文献 · Semin Nucl Med · 2025-08-30

本文综述放射性诊疗一体化在神经内分泌肿瘤和前列腺癌等领域的临床应用进展,指出物流、资金、资源、政治稳定性及监管与教育等障碍限制其广泛实施,并汇总国际原子能机构提出的教育训练、药物生产研发、研究能力与质量管理等专家策略以促进可持续公平可及。

要点

  • 放射性诊疗一体化已用于神经内分泌肿瘤和前列腺癌等临床实践。
  • 实施障碍包括物流、资金、资源稀缺、政治不稳定及监管教育壁垒。
  • IAEA建议加强教育训练、药物生产研发、研究能力与质量管理体系。

核心结论

  • 放射性诊疗一体化发展迅速但广泛实施受多重障碍限制,需协调缓解策略以实现可持续公平可及。

研究设计与样本

  • 本文为综述,概述全球放射性诊疗一体化现状、识别实施障碍并汇总国际原子能机构专家策略与建议。

主要发现

  • 过去十年放射性诊疗一体化势头显著,多种放射性药物已进入临床实践,尤其用于神经内分泌肿瘤和前列腺癌。
  • 新型药物管线持续增长,为常规治疗耐药肿瘤患者提供有前景的治疗选择。
  • 实施受物流限制、财务限制、资源稀缺、政治不稳定以及监管和教育壁垒阻碍。

关键数值与推荐

  • 缓解策略聚焦加强教育与培训、扩大放射性药物生产与开发、提升研究能力及建立稳健的质量管理系统。

临床怎么用

  • 核医学科智能体医生可参考IAEA策略,在本科室推动教育训练、药物可及性、研究能力与质量管理建设。

局限性

  • 本文为综述,未报告原始研究的具体样本量、效应值或统计检验结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiotheranostics represent a cutting-edge advancement in the management of noncommunicable diseases, integrating diagnostic imaging with targeted radiotherapy in a single, personalized approach. Over the past decade, the field has gained substantial momentum, with several radiopharmaceuticals now incorporated into clinical practice, most notably for neuroendocrine tumors and prostate cancer. The pipeline of novel agents continues to grow, offering promising therapeutic options for patients with cancers resistant to conventional therapies. Despite these advances, the broad implementation of radiotheranostics is impeded by several challenges, including logistical constraints, financial limitations, resource scarcity, political instability, and regulatory and educational barriers. Overcoming these obstacles requires coordinated mitigation strategies focused on strengthening education and training, expanding radiopharmaceutical production and development, enhancing research capacity, and establishing robust quality management systems. This review provides a comprehensive overview of the current global landscape of radiotheranostics, identifies key implementation barriers, and offers expert-driven strategies and recommendations from the International Atomic Energy Agency to support sustainable and equitable access to radiotheranostics.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Al-Ibraheem A, Brink A, Lee ST, et al. Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access. Semin Nucl Med. 2025. PMID: 40887378. doi:10.1053/j.semnuclmed.2025.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。